Treatment rationale and design of a phase II study of narrow-band ultraviolet B phototherapy for cutaneous steroid-refractory acute graft-vs-host disease following allogenic stem-cell transplantation.
Medicine (Baltimore)
; 98(28): e16372, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-31305435
Full text:
1
Database:
MEDLINE
Main subject:
Skin Diseases
/
Ultraviolet Therapy
/
Clinical Trials, Phase II as Topic
/
Stem Cell Transplantation
/
Graft vs Host Disease
Type of study:
Etiology_studies
/
Guideline
/
Prognostic_studies
Language:
En
Journal:
Medicine (Baltimore)
Year:
2019
Type:
Article